Trademarkia Logo

Canada

C$
MYXREDLIN
REGISTERED

on 4 Dec 2019

Last Applicant/ Owned by

BAXTER INTERNATIONAL INC.

One Baxter ParkwayDeerfield, IL 60015-4633

US

Serial Number

1821450 filed on 6th Feb 2017

Registration Number

TMA1065173 registered on 4th Dec 2019

Registration expiry Date

4th Dec 2029

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

MYXREDLIN

Trademark usage description

pharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders namely hyperthyroidism, h Read More

Classification Information


Class [005]
Pharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders namely hyperthyroidism, hypothyroidism, hyperglycemia, hypoglycemia, adrenal insufficiency and Cushing syndrome; pharmaceutical preparations containing insulin


Classification kind code

11

Mark Details


Serial Number

1821450

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 2th May 2018
Advertised
Submitted for opposition 67
on 2th May 2018
Agent Name Changed
Submitted for opposition 68
on 2th May 2018
Rep for Service Name Changed
Submitted for opposition 26
on 12th Apr 2018
Approved
Submitted for opposition 27
on 22nd Feb 2018
Approval Notice Sent
Submitted for opposition 22
on 1st Dec 2017
Search Recorded
Submitted for opposition 20
on 1st Dec 2017
Examiner's First Report
Submitted for opposition 31
on 7th Feb 2017
Formalized
Submitted for opposition 30
on 6th Feb 2017
Filed
Submitted for opposition 1
on 6th Feb 2017
Created